An integrated, specialty healthcare company.
Concordia is an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products. Concordia trades on the NASDAQ Global Select Market® under the symbol CXRX, and on the Toronto Stock Exchange under the symbol CXR.
- Q4 2017 Concordia International Earnings Conference Call March 8, 2018
- Q3 2017 Concordia International Earnings Conference Call November 14, 2017
- Concordia International DELIVER conference call September 6, 2017
For investor-related queries, please contact:
1 905 842 5150